Copyright Reports & Markets. All rights reserved.

Global Surgical Tumor Ablation Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Surgical Tumor Ablation Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Radiofrequency Ablation
      • 1.4.3 Microwave Ablation
      • 1.4.4 Cryoablation
      • 1.4.5 Others
    • 1.5 Market by Application
      • 1.5.1 Global Surgical Tumor Ablation Market Share by Application (2019-2025)
      • 1.5.2 Liver Cancer
      • 1.5.3 Breast Cancer
      • 1.5.4 Lung Cancer
      • 1.5.5 Prostate Cancer
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Surgical Tumor Ablation Market Size
    • 2.2 Surgical Tumor Ablation Growth Trends by Regions
      • 2.2.1 Surgical Tumor Ablation Market Size by Regions (2019-2025)
      • 2.2.2 Surgical Tumor Ablation Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Surgical Tumor Ablation Market Size by by Players
      • 3.1.1 Global Surgical Tumor Ablation Revenue by by Players (2014-2019)
      • 3.1.2 Global Surgical Tumor Ablation Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Surgical Tumor Ablation Market Concentration Ratio (CR5 and HHI)
    • 3.2 Surgical Tumor Ablation Key Players Head office and Area Served
    • 3.3 Key Players Surgical Tumor Ablation Product/Solution/Service
    • 3.4 Date of Enter into Surgical Tumor Ablation Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Surgical Tumor Ablation Market Size by Type (2014-2019)
    • 4.2 Global Surgical Tumor Ablation Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Surgical Tumor Ablation Market Size (2014-2019)
    • 5.2 Surgical Tumor Ablation Key Players in North America
    • 5.3 North America Surgical Tumor Ablation Market Size by Type
    • 5.4 North America Surgical Tumor Ablation Market Size by Application

    6 Europe

    • 6.1 Europe Surgical Tumor Ablation Market Size (2014-2019)
    • 6.2 Surgical Tumor Ablation Key Players in Europe
    • 6.3 Europe Surgical Tumor Ablation Market Size by Type
    • 6.4 Europe Surgical Tumor Ablation Market Size by Application

    7 China

    • 7.1 China Surgical Tumor Ablation Market Size (2014-2019)
    • 7.2 Surgical Tumor Ablation Key Players in China
    • 7.3 China Surgical Tumor Ablation Market Size by Type
    • 7.4 China Surgical Tumor Ablation Market Size by Application

    8 Japan

    • 8.1 Japan Surgical Tumor Ablation Market Size (2014-2019)
    • 8.2 Surgical Tumor Ablation Key Players in Japan
    • 8.3 Japan Surgical Tumor Ablation Market Size by Type
    • 8.4 Japan Surgical Tumor Ablation Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Surgical Tumor Ablation Market Size (2014-2019)
    • 9.2 Surgical Tumor Ablation Key Players in Southeast Asia
    • 9.3 Southeast Asia Surgical Tumor Ablation Market Size by Type
    • 9.4 Southeast Asia Surgical Tumor Ablation Market Size by Application

    10 India

    • 10.1 India Surgical Tumor Ablation Market Size (2014-2019)
    • 10.2 Surgical Tumor Ablation Key Players in India
    • 10.3 India Surgical Tumor Ablation Market Size by Type
    • 10.4 India Surgical Tumor Ablation Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Surgical Tumor Ablation Market Size (2014-2019)
    • 11.2 Surgical Tumor Ablation Key Players in Central & South America
    • 11.3 Central & South America Surgical Tumor Ablation Market Size by Type
    • 11.4 Central & South America Surgical Tumor Ablation Market Size by Application

    12 International Players Profiles

    • 12.1 Galil Medical
      • 12.1.1 Galil Medical Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Surgical Tumor Ablation Introduction
      • 12.1.4 Galil Medical Revenue in Surgical Tumor Ablation Business (2014-2019))
      • 12.1.5 Galil Medical Recent Development
    • 12.2 Misonix
      • 12.2.1 Misonix Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Surgical Tumor Ablation Introduction
      • 12.2.4 Misonix Revenue in Surgical Tumor Ablation Business (2014-2019)
      • 12.2.5 Misonix Recent Development
    • 12.3 HealthTronics
      • 12.3.1 HealthTronics Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Surgical Tumor Ablation Introduction
      • 12.3.4 HealthTronics Revenue in Surgical Tumor Ablation Business (2014-2019)
      • 12.3.5 HealthTronics Recent Development
    • 12.4 AngioDynamics
      • 12.4.1 AngioDynamics Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Surgical Tumor Ablation Introduction
      • 12.4.4 AngioDynamics Revenue in Surgical Tumor Ablation Business (2014-2019)
      • 12.4.5 AngioDynamics Recent Development
    • 12.5 Covidien
      • 12.5.1 Covidien Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Surgical Tumor Ablation Introduction
      • 12.5.4 Covidien Revenue in Surgical Tumor Ablation Business (2014-2019)
      • 12.5.5 Covidien Recent Development
    • 12.6 Boston Scientific Corporation
      • 12.6.1 Boston Scientific Corporation Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Surgical Tumor Ablation Introduction
      • 12.6.4 Boston Scientific Corporation Revenue in Surgical Tumor Ablation Business (2014-2019)
      • 12.6.5 Boston Scientific Corporation Recent Development
    • 12.7 Medtronic
      • 12.7.1 Medtronic Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Surgical Tumor Ablation Introduction
      • 12.7.4 Medtronic Revenue in Surgical Tumor Ablation Business (2014-2019)
      • 12.7.5 Medtronic Recent Development
    • 12.8 SonaCare Medical
      • 12.8.1 SonaCare Medical Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Surgical Tumor Ablation Introduction
      • 12.8.4 SonaCare Medical Revenue in Surgical Tumor Ablation Business (2014-2019)
      • 12.8.5 SonaCare Medical Recent Development
    • 12.9 EDAP TMS
      • 12.9.1 EDAP TMS Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Surgical Tumor Ablation Introduction
      • 12.9.4 EDAP TMS Revenue in Surgical Tumor Ablation Business (2014-2019)
      • 12.9.5 EDAP TMS Recent Development
    • 12.10 NeuWave Medical
      • 12.10.1 NeuWave Medical Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Surgical Tumor Ablation Introduction
      • 12.10.4 NeuWave Medical Revenue in Surgical Tumor Ablation Business (2014-2019)
      • 12.10.5 NeuWave Medical Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Surgical Tumor Ablation is a minimally invasive technique that is commonly used in the treatment of tumors of the liver, kidney, bone, and lung. It is an important option for people who have failed chemotherapy or radiotherapy or are not surgical candidates.
      In 2018, the global Surgical Tumor Ablation market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Surgical Tumor Ablation status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Surgical Tumor Ablation development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Galil Medical
      Misonix
      HealthTronics
      AngioDynamics
      Covidien
      Boston Scientific Corporation
      Medtronic
      SonaCare Medical
      EDAP TMS
      NeuWave Medical

      Market segment by Type, the product can be split into
      Radiofrequency Ablation
      Microwave Ablation
      Cryoablation
      Others

      Market segment by Application, split into
      Liver Cancer
      Breast Cancer
      Lung Cancer
      Prostate Cancer
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Surgical Tumor Ablation status, future forecast, growth opportunity, key market and key players.
      To present the Surgical Tumor Ablation development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Surgical Tumor Ablation are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now